Literature DB >> 20090978

Synthesis and biological evaluation of selective CXCR4 antagonists containing alkene dipeptide isosteres.

Tetsuo Narumi1, Ryoko Hayashi, Kenji Tomita, Kazuya Kobayashi, Noriko Tanahara, Hiroaki Ohno, Takeshi Naito, Eiichi Kodama, Masao Matsuoka, Shinya Oishi, Nobutaka Fujii.   

Abstract

A set of cyclic peptide analogues of a selective CXCR4 antagonist FC131 [cyclo(-d-Tyr-Arg-Arg-Nal-Gly-)] were synthesized and bioevaluated. Using (E)-alkene and (Z)-fluoroalkene dipeptide isosteres for Arg-Arg and Arg-Nal substructures, indispensable or the partial contribution of the two peptide bonds to the CXCR4 antagonism and anti-HIV activity was demonstrated. FC131 and the analogues were shown to selectively inhibit SDF-1 binding to CXCR4, whereas no inhibition of binding of SDF-1 to CXCR7 was observed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20090978     DOI: 10.1039/b917236j

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  13 in total

Review 1.  Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).

Authors:  Won-Tak Choi; Srinivas Duggineni; Yan Xu; Ziwei Huang; Jing An
Journal:  J Med Chem       Date:  2011-12-02       Impact factor: 7.446

2.  The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.

Authors:  Stéphanie Gravel; Camille Malouf; Philip E Boulais; Yamina A Berchiche; Shinya Oishi; Nobutaka Fujii; Richard Leduc; Daniel Sinnett; Nikolaus Heveker
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

Review 3.  Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.

Authors:  Won-Tak Choi; Yilei Yang; Yan Xu; Jing An
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

4.  Potent CXCR4 antagonists containing amidine type Peptide bond isosteres.

Authors:  Eriko Inokuchi; Shinya Oishi; Tatsuhiko Kubo; Hiroaki Ohno; Kazuya Shimura; Masao Matsuoka; Nobutaka Fujii
Journal:  ACS Med Chem Lett       Date:  2011-03-28       Impact factor: 4.345

Review 5.  Peptide and protein-based inhibitors of HIV-1 co-receptors.

Authors:  Horst A von Recum; Jonathan K Pokorski
Journal:  Exp Biol Med (Maywood)       Date:  2013-05

Review 6.  Targeting stem cell niches and trafficking for cardiovascular therapy.

Authors:  Nicolle Kränkel; Gaia Spinetti; Silvia Amadesi; Paolo Madeddu
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

7.  Palladium-Catalyzed Fluorination of Cyclic Vinyl Triflates: Effect of TESCF3 as an Additive.

Authors:  Yuxuan Ye; Takashi Takada; Stephen L Buchwald
Journal:  Angew Chem Int Ed Engl       Date:  2016-11-15       Impact factor: 15.336

8.  Novel compounds containing multiple guanide groups that bind the HIV coreceptor CXCR4.

Authors:  Royce A Wilkinson; Seth H Pincus; Joyce B Shepard; Sarah K Walton; Edward P Bergin; Mohamed Labib; Martin Teintze
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

9.  Synthesis of a Chloroalkene Dipeptide Isostere-Containing Peptidomimetic and Its Biological Application.

Authors:  Takuya Kobayakawa; Yudai Matsuzaki; Kentaro Hozumi; Wataru Nomura; Motoyoshi Nomizu; Hirokazu Tamamura
Journal:  ACS Med Chem Lett       Date:  2017-12-27       Impact factor: 4.345

Review 10.  Small molecule inhibitors of CXCR4.

Authors:  Bikash Debnath; Shili Xu; Fedora Grande; Antonio Garofalo; Nouri Neamati
Journal:  Theranostics       Date:  2013-01-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.